• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Wednesday, October 4, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Mode-of-action of T-cell immunotherapies in focus

Bioengineer by Bioengineer
July 25, 2022
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A new 3D imaging technique brings the working mode of T-cell immunotherapies into live view. T-cell immunotherapy is already leading to promising results in some children with leukemia. Researchers plan to use the new imaging technique to improve T-cell therapies for solid tumors.

Mode-of-action of T-cell immunotherapies in focus

Credit: Research group dr. Anne Rios – Princess Máxima Center for Pedriatic Oncology, Utrecht, the Netherlands.

A new 3D imaging technique brings the working mode of T-cell immunotherapies into live view. T-cell immunotherapy is already leading to promising results in some children with leukemia. Researchers plan to use the new imaging technique to improve T-cell therapies for solid tumors.

T-cell therapies, such as CAR-T cells, are a promising type of immunotherapy that is already showing results in treating children with leukemia. These kind of therapies use the own immune system. T-cells, a type of white blood cell, which have been modified in the lab are administered and subsequently attack the tumor in a targeted manner. Effective T-cell therapies are also being sought for solid tumors, such as neuroblastoma, sarcoma and kidney tumors. However, to improve their clinical efficacy, we need to better understand the solid tumor-targeting behavior of T-cells. That’s why the lab of dr. Anne Rios, specialized in 3D imaging at the Princess Máxima Center and Oncode investigator, teamed up with dr. Zsolt Sebestyén and Prof. dr. Jürgen Kuball, T-cell therapy experts and group leaders at UMC Utrecht, and the group of Prof. dr. Hans Clevers, organoid specialist and visiting researcher at the Máxima and the Hubrecht Institute. The results of this collaborative research endeavor were published today (Monday) in the leading journal Nature Biotechnology.

A wealth of fundamental knowledge

Lead authors of the publication dr. Florijn Dekkers and dr. Maria Alieva from the Rios group developed an imaging and analysis technology, BEHAV3D, that allows to analyze the interaction between T-cell therapies and solid mini tumors, also known as tumor organoids, live and three-dimensionally. Florijn Dekkers: ‘Unique about this approach is that we are looking at cell therapy efficacy by studying the behavior of the T-cells. In total, we studied the behavior of over 150,000 engineered T cells. This revealed a huge variety in behavior, like very potent behaviors, such as killing of multiple tumor cells in sequence, but also ineffective behaviors, with cells just sitting around and doing nothing. This suggested to us that there is room to improve clinical efficacy by promoting the most potent tumor-targeting behaviors.’

Maria Alieva: ‘To be able to stir T-cell therapies towards their most effective behaviors, we need to know the underlying mechanisms that dictate this behavior. Therefore, I developed a method that for the first time links the behavior of the cell to the genes that cause this behavior. With it, we were able to identify the specific gene signature of highly potent T cells that are able to kill many tumor cells in a row. Thanks to BEHAV3D and the use of mini-tumors grown from tumor tissue of children and adults, we can now gather a wealth of fundamental knowledge about the behavior and ability of T cells to target solid tumors.’

Improving targeting

Dr. Anne Rios: ’We initially looked at the behavior of so-called TEG cells, a highly promising therapy based on T-cells that are activated once they notice metabolism changes in tumor cells, developed in the lab of our collaborators; Zsolt Sebestyén and Jürgen Kuball. However, we were able to apply BEHAV3D to different kinds of T cell therapies, as well as cancer subtypes. Therefore, we believe that this platform can be very useful for further improving the targeted attack on solid tumors by the various T-cell therapies currently under development.’



Journal

Nature Biotechnology

DOI

10.1038/s41587-022-01397-w

Method of Research

Observational study

Subject of Research

Human tissue samples

Article Title

Uncovering the mode of action of engineered T cells in patient cancer organoids

Article Publication Date

25-Jul-2022

Share12Tweet8Share2ShareShareShare2

Related Posts

Proposed model for how human coronavirus HKU1 engages the host cell.

Revealing the ‘sweet secrets’ of coronavirus cell entry

October 4, 2023
Assembly Theory

New “Assembly Theory” unifies physics and biology to explain evolution and complexity

October 4, 2023

Female animals may learn mate preferences based on what sets other females’ choices apart from the crowd

October 3, 2023

Newly established Bulgarian Barcode of Life to support biodiversity conservation in the country

October 3, 2023

POPULAR NEWS

  • blank

    Microbe Computers

    59 shares
    Share 24 Tweet 15
  • A pioneering study from Politecnico di Milano sheds light on one of the still poorly understood aspects of cancer

    35 shares
    Share 14 Tweet 9
  • Fossil spines reveal deep sea’s past

    34 shares
    Share 14 Tweet 9
  • Scientists go ‘back to the future,’ create flies with ancient genes to study evolution

    75 shares
    Share 30 Tweet 19

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Case Western Reserve University and University Hospitals researchers awarded five-year, $11.2 million federal grant to study esophagus cancers

Revealing the ‘sweet secrets’ of coronavirus cell entry

These robots helped understand how insects evolved two distinct strategies of flight

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 56 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In